Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:rostaa02

Total Results:

158


Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses [Case Report]

Rostagno, Agueda; Frizzera, Glauco; Ylagan, Lourdes; Kumar, Asok; Ghiso, Jorge; Gallo, Gloria
Tumoral monoclonal immunoglobulin (Ig) light chain non-fibrillar deposits ('aggregomas'), which can be considered analogous to solitary light chain amyloidomas, are a rare presenting feature of B-cell dyscrasias. It is not certain if they are truly localized or if in reality they represent an initial expression of a silent systemic non-amyloid light chain deposition disease (LCDD). This report describes three patients, two of whom presented with cervical masses and the third with a solitary lung nodule, each comprising granular aggregates of monoclonal kappa light chain. Extracted deposits from the lymph node of one patient were shown by N-terminal amino acid sequence analysis to belong to the variable-region kappa I (Vkappa I) light chain subgroup, the first reported kappa-LCDD protein encoded by the L9 gene and the first report of an expressed protein related to this gene. Extracted deposits from the lung nodule of the second patient belonged to the Vkappa IV light chain subgroup encoded by the B3 germ line gene. The N-terminal amino acid sequences of the light chains from the aggregomas were compared with the related germ line sequences and to the N-terminal amino acid sequences of the nine other known kappa-LCDD light chains reported thus far from patients with systemic LCDD
PMID: 12358904
ISSN: 0007-1048
CID: 39580

Morphological evidence of the activation of the classical complement pathway in the BRI gene-related dementias [Meeting Abstract]

Holton, J; Lashley, T; Revesz, T; Rostagno, A; Frangione, B; Ghiso, J
ISI:000177465300756
ISSN: 0197-4580
CID: 32416

Familial British dementia (FBD), a form of cerebral amyloidosis with systemic amyloid deposition [Meeting Abstract]

Revesz, T; Lashley, T; Ganguly, M; Strand, C; Plant, G; Holton, J; Ghiso, J; Rostagno, A; Frangione, B
ISI:000177465301725
ISSN: 0197-4580
CID: 32434

Involvement of apolipoprotein J (apo J) in brain amyloidosis [Meeting Abstract]

Ghiso, J; Calero, M; Magnotti, L; Ng, D; Rostagno, A; Frangione, B
ISI:000177465301449
ISSN: 0197-4580
CID: 32427

Complement activation in chromosome 13 dementias [Meeting Abstract]

Rostagno, A; Magnotti, L; Tomidokoro, Y; Frangione, B; Ghiso, J; Revesz, T; Lashley, T; Holton, J
ISI:000177465301631
ISSN: 0197-4580
CID: 32431

Co-existence of amyloid ADan and amyloid-beta in familial Danish dementia [Meeting Abstract]

Tomidokoro, Y; Fleire, S; Rostagno, A; Frangione, B; Ghiso, J; Lashley, T; Holton, J; Houlden, H; Revesz, T; Bojsen-Moller, M; Braendgaard, H; Plant, G
ISI:000177465301632
ISSN: 0197-4580
CID: 32432

Tau in familial Danish dementia brain is similar, but not identical, to that found in familial British dementia and PHF- tau in Alzheimer's disease [Meeting Abstract]

Hanger, D; Gibb, G; Anderton, B; Ghiso, J; Rostagno, A; Frangione, B; Holton, J; Revesz, T
ISI:000177465301810
ISSN: 0197-4580
CID: 32437

Sporadic and familial cerebral amyloid angiopathies

Revesz, Tamas; Holton, Janice L; Lashley, Tammaryn; Plant, Gordon; Rostagno, Agueda; Ghiso, Jorge; Frangione, Blas
Cerebral amyloid angiopathy (CAA) is the term used to describe deposition of amyloid in the walls of arteries, arterioles and, less often, capillaries and veins of the central nervous system. CAAs are an important cause of cerebral hemorrhage and may also result in ischemic lesions and dementia. A number of amyloid proteins are known to cause CAA. The most common sporadic CAA, caused by A beta deposition, is associated with aging and is a common feature of Alzheimer disease (AD). CAA occurs in several familial conditions, including hereditary cerebral hemorrhage with amyloidosis of Icelandic type caused by deposition of mutant cystatin C, hereditary cerebral hemorrhage with amyloidosis Dutch type and familial AD with deposition of either A beta variants or wild-type A beta, the transthyretin-related meningo-vascular amyloidoses, gelsolin as well as familial prion disease-related CAAs and the recently described BRI2 gene-related CAAs in familial British dementia and familial Danish dementia. This review focuses on the morphological, biochemical, and genetic aspects as well as the clinical significance of CAAs with special emphasis on the BRI2 gene-related cerebrovascular amyloidoses. We also discuss data relevant to the pathomechanism of the different forms of CAA with an emphasis on the most common A beta-related types
PMID: 12146803
ISSN: 1015-6305
CID: 42009

Binding of polymeric IgG to fibronectin in extracellular matrices: an in vitro paradigm for immune-complex deposition

Rostagno, Agueda A; Gallo, Gloria; Gold, Leslie I
We have previously shown a biochemical interaction between fibronectin (Fn) and polymeric immunoglobulins (Igs), that we localized to the fourth and fifth N-terminal type I repeats (4F1.5F1) in Fn and the Fc portion of IgG. Therefore, we hypothesized that Fn, as a constituent of the extracellular matrix (ECM) may directly bind circulating immune complexes (ICs) causing their deposition, thereby contributing to the pathogenesis of IC diseases. As an in vitro paradigm to test this idea, we have generated Fn-containing ECMs from varied cells in culture and demonstrated a saturable dose-dependent binding of aggregated (agg) IgG, as a prototype of ICs, as well as the binding of both heat and cold aggregated purified type I cryoglobulins (CGs) to these ECMs. No binding was observed to ECMs (Matrigel) that do not contain Fn. Characteristic of our previous findings, polymeric but not monomeric IgG bound to the acellular Fn-containing ECMs. To further demonstrate the specificity of the interaction and implicate matrix Fn in the binding of aggIgG, complete inhibition of binding of aggIgG to Fn was achieved by blocking Fn on the ECMs with anti-Fn antiserum and by preincubation of the Ig aggregates with anti-human IgG antibodies. By competing the binding interaction with fluid phase Fn and the Ig-binding site on Fn, 4F(1).5F(1), 70% inhibition was obtained. Additional experiments performed with purified CGs show that an identical dose-dependent increase in Fn binding occurred using both preformed and forming cryoprecipitates suggesting that Fn does not confer cryoprecipitation of CGs and that the specific association of Fn with cryoprecipitates probably results from their polymeric configuration. Our results support the notion that Fn, as it exits in expanding ECMs characteristic of glomerulonephropathies and rheumatoid synovial disease, specifically interacts with complexed/polymeric Igs, thereby perpetuating IC deposition and playing a role in the pathogenesis of IC diseases
PMID: 12044777
ISSN: 0161-5890
CID: 39424

Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta [Case Report]

Holton, Janice L; Lashley, Tammaryn; Ghiso, Jorge; Braendgaard, Hans; Vidal, Ruben; Guerin, Christopher J; Gibb, Graham; Hanger, Diane P; Rostagno, Agueda; Anderton, Brian H; Strand, Catherine; Ayling, Hilary; Plant, Gordon; Frangione, Blas; Bojsen-Moller, Marie; Revesz, Tamas
Familial Danish dementia (FDD) is pathologically characterized by widespread cerebral amyloid angiopathy (CAA), parenchymal protein deposits, and neurofibrillary degeneration. FDD is associated with a mutation of the BRI2 gene located on chromosome 13. In FDD there is a decamer duplication, which abolishes the normal stop codon, resulting in an extended precursor protein and the release of an amyloidogenic fragment, ADan. The aim of this study was to describe the major neuropathological changes in FDD and to assess the distribution of ADan lesions, neurofibrillary pathology, glial, and microglial response using conventional techniques, immunohistochemistry, confocal microscopy, and immunoelectron microscopy. We showed that ADan is widely distributed in the central nervous system (CNS) in the leptomeninges, blood vessels, and parenchyma. A predominance of parenchymal pre-amyloid (non-fibrillary) lesions was found. Abeta was also present in a proportion of both vascular and parenchymal lesions. There was severe neurofibrillary pathology, and tau immunoblotting revealed a triplet electrophoretic migration pattern comparable with PHF-tau. FDD is a novel form of CNS amyloidosis with extensive neurofibrillary degeneration occurring with parenchymal, predominantly pre-amyloid rather than amyloid, deposition. These findings support the notion that parenchymal amyloid fibril formation is not a prerequisite for the development of neurofibrillary tangles. The significance of concurrent ADan and Abeta deposition in FDD is under further investigation
PMID: 11895040
ISSN: 0022-3069
CID: 42011